Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)
Clinical trial NCT06437223 · COMPLETED
Trial details
- NCT number
- NCT06437223
- Sponsor
- Inflammx Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2025-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.